Paul A. Volberding
Dr Volberding has served on data and safety monitoring boards for Merck. (Updated 07/24/18)

Constance A. Benson, MD
Dr Benson has served on a data and safety monitoring board for GlaxoSmithKline/ViiV Healthcare. She has received research grants awarded to her institution from Gilead Sciences, Inc. Disclosure information for her spouse, Dr Schooley, is elsewhere on this page. (Updated 07/24/18)

Peter C. Cassat, JD
Mr Cassat has no relevant financial affiliations to disclose. (Updated 10/03/18)

Judith S. Currier, MD
Dr Currier has received research grants awarded to her institution from Theratechnologies. (Updated 04/04/18)

Carlos del Rio, MD
Dr del Rio has no relevant financial affiliations to disclose. (Updated 11/28/18)

Roy M. Gulick, MD, MPH
Dr Gulick has no relevant financial affiliations to disclose. (Updated 04/03/18)

Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA
Dr Marrazzo currently serves on data and safety monitoring board for Gilead Science, Inc. (Updated 08/11/17)

Douglas D. Richman, MD
Dr Richman has been a consultant to Antiva Biosciences; Gilead Sciences, Inc; and Viriome, Inc. (Updated 12/06/18)

Michael S. Saag, MD
Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc, Merck, and ViiV Healthcare. He has also served as a consultant for Gilead Sciences, Inc, Merck, and ViiV Healthcare. (Updated 11/30/18)

Robert T. Schooley, MD
Dr Schooley has served as a consultant to CytoDyn, Pfizer, and Vir Biotechnology. He has received grant support from Gilead Sciences, Inc, and holds stock or stock options in Antiva Biosciences and CytoDyn. His spouse serves on a data and safety monitoring board for GlaxoSmithKline/ViiV Healthcare and has received research grants awarded to her institution from Gilead Sciences, Inc. (Updated 09/12/18)

Donna M. Jacobsen, BS
Ms Jacobsen has no relevant financial affiliations to disclose. (Updated 12/11/18)